Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
1.
BMC Health Serv Res ; 21(1): 1097, 2021 Oct 15.
Article in English | MEDLINE | ID: mdl-34654429

ABSTRACT

BACKGROUND: Studies estimate that circumcising men between the ages of 20-30 years who have exhibited previous risky sexual behaviour could reduce overall HIV prevalence. Demand creation strategies for medical male circumcision (MMC) targeting men in this age group may significantly impact these prevalence rates. OBJECTIVES: The objective of this study is to evaluate the cost-effectiveness and cost-benefit of an implementation science, pre-post study designed to increase the uptake of male circumcision for ages 25-49 at a fixed MMC clinic located in Gauteng Province, South Africa. METHODS: A health care provider perspective was utilised to collect all costs. Costs were compared between the standard care scenario of routine outreach strategies and a full intervention strategy. Cost-effectiveness was measured as cost per mature man enrolled and cost per mature man circumcised. A cost-benefit analysis was employed by using the Bernoulli model to estimate the cases of HIV averted due to medical male circumcision (MMC), and subsequently translated to averted medical costs. RESULTS: In the 2015 intervention, the cost of the intervention was $9445 for 722 men. The total HIV treatment costs averted due to the intervention were $542,491 from a public care model and $378,073 from a private care model. The benefit-cost ratio was 57.44 for the public care model and 40.03 for the private care model. The net savings of the intervention were $533,046 or $368,628 - depending on treatment in a public or private setting. CONCLUSIONS: The intervention was cost-effective compared to similar MMC demand interventions and led to statistically significant cost savings per individual enrolled.


Subject(s)
Circumcision, Male , HIV Infections , Adult , Cost-Benefit Analysis , HIV Infections/epidemiology , HIV Infections/prevention & control , Humans , Male , Middle Aged , Sexual Behavior , South Africa/epidemiology , Young Adult
2.
Int J Tuberc Lung Dis ; 18(4): 438-40, 2014 Apr.
Article in English | MEDLINE | ID: mdl-24670699

ABSTRACT

In a mobile deployment of Xpert(®) MTB/RIF (Xpert) at the public event for 2012 South African World TB Day, Xpert testing was offered to tuberculosis (TB) symptomatic clients from gold mining and surrounding communities. Considerations before implementation included effective TB symptom screening; safe, effective sputum collection; uninterrupted electricity supply; stringent instrument verification and provision of on-site results. Public event Xpert testing is feasible; however, the case-finding rate was very low (0.7%). We recommend exploring enhanced symptom screening algorithms to improve pre-test probability, cost-effectiveness analysis, exploring alternate electrical fail-safes and on-site data connectivity and improving management of client expectations.


Subject(s)
Bacteriological Techniques , Community Health Services/organization & administration , DNA, Bacterial/genetics , Mobile Health Units/organization & administration , Molecular Diagnostic Techniques , Mycobacterium tuberculosis/genetics , Tuberculosis, Pulmonary/diagnosis , DNA, Bacterial/isolation & purification , Feasibility Studies , Health Services Accessibility/organization & administration , Humans , Mycobacterium tuberculosis/isolation & purification , Outcome and Process Assessment, Health Care , Predictive Value of Tests , Prevalence , Program Evaluation , South Africa/epidemiology , Sputum/microbiology , Time Factors , Tuberculosis, Pulmonary/epidemiology , Tuberculosis, Pulmonary/microbiology
SELECTION OF CITATIONS
SEARCH DETAIL
...